Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mylan Pharmaceuticals Inc

Clinical trials sponsored by Mylan Pharmaceuticals Inc, explained in plain language.

Now part of Viatris Inc. VTRS NASDAQ

A pharmaceutical company focused on generics and specialty medicines, now part of Viatris.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Could a biosimilar eye injection offer a new way to treat diabetic macular edema?

Disease control Completed

This trial is testing MYL-1701P, a proposed biosimilar to the existing eye medication Eylea, in people with diabetic macular edema who have already completed an earlier study with the same drug. The goal is to see if continued treatment with MYL-1701P is safe and effective over a…

Phase: PHASE3 • Sponsor: Mylan Pharmaceuticals Inc • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC